Interplay of heavy chain introns influences efficient transcript splicing and affects product quality of recombinant biotherapeutic antibodies from CHO cells
ABSTRACTIntrons are included in genes encoding therapeutic proteins for their well-documented function of boosting expression. However, mis-splicing of introns in recombinant immunoglobulin (IgG) heavy chain (HC) transcripts can produce amino acid sequence product variants. These variants can affect...
Main Authors: | Emma Kelsall, Claire Harris, Titash Sen, Diane Hatton, Sarah Dunn, Suzanne Gibson |
---|---|
Format: | Article |
Language: | English |
Published: |
Taylor & Francis Group
2023-12-01
|
Series: | mAbs |
Subjects: | |
Online Access: | https://www.tandfonline.com/doi/10.1080/19420862.2023.2242548 |
Similar Items
-
Splice and Dice: Intronic microRNAs, Splicing and Cancer
by: Alex C. H. Wong, et al.
Published: (2021-09-01) -
First Identification of Rare Exonic and Deep Intronic Splice-Altering Variants in Patients With Beta-Sarcoglycanopathy
by: Zhiying Xie, et al.
Published: (2022-06-01) -
Updated Progress on Group II Intron Splicing Factors in Plant Chloroplasts
by: Chu Zeng, et al.
Published: (2022-09-01) -
Introme accurately predicts the impact of coding and noncoding variants on gene splicing, with clinical applications
by: Patricia J. Sullivan, et al.
Published: (2023-05-01) -
Minor Intron Splicing from Basic Science to Disease
by: Ettaib El Marabti, et al.
Published: (2021-06-01)